あすか製薬ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/03/09 | 1,048 | 1,084 | 1,045 | 1,062 | +9 | +0.9% | 120,200 |
| 2022/03/08 | 1,040 | 1,060 | 1,040 | 1,053 | -5 | -0.5% | 79,600 |
| 2022/03/07 | 1,077 | 1,084 | 1,043 | 1,058 | -38 | -3.5% | 101,400 |
| 2022/03/04 | 1,107 | 1,116 | 1,085 | 1,096 | -27 | -2.4% | 92,100 |
| 2022/03/03 | 1,139 | 1,142 | 1,118 | 1,123 | +4 | +0.4% | 57,400 |
| 2022/03/02 | 1,110 | 1,135 | 1,110 | 1,119 | -19 | -1.7% | 65,500 |
| 2022/03/01 | 1,150 | 1,160 | 1,131 | 1,138 | -8 | -0.7% | 61,300 |
| 2022/02/28 | 1,116 | 1,153 | 1,114 | 1,146 | +34 | +3.1% | 101,000 |
| 2022/02/25 | 1,100 | 1,122 | 1,089 | 1,112 | +30 | +2.8% | 72,800 |
| 2022/02/24 | 1,098 | 1,120 | 1,072 | 1,082 | -4 | -0.4% | 121,100 |
| 2022/02/22 | 1,060 | 1,093 | 1,056 | 1,086 | +18 | +1.7% | 80,600 |
| 2022/02/21 | 1,077 | 1,081 | 1,056 | 1,068 | -10 | -0.9% | 36,200 |
| 2022/02/18 | 1,055 | 1,078 | 1,044 | 1,078 | +8 | +0.7% | 45,200 |
| 2022/02/17 | 1,067 | 1,085 | 1,062 | 1,070 | +5 | +0.5% | 65,400 |
| 2022/02/16 | 1,050 | 1,066 | 1,049 | 1,065 | +23 | +2.2% | 100,400 |
| 2022/02/15 | 1,047 | 1,064 | 1,033 | 1,042 | -1 | -0.1% | 96,600 |
| 2022/02/14 | 1,024 | 1,050 | 1,007 | 1,043 | -3 | -0.3% | 97,700 |
| 2022/02/10 | 1,068 | 1,068 | 1,030 | 1,046 | -12 | -1.1% | 123,600 |
| 2022/02/09 | 1,046 | 1,059 | 1,025 | 1,058 | +12 | +1.1% | 143,900 |
| 2022/02/08 | 1,041 | 1,061 | 1,019 | 1,046 | +9 | +0.9% | 162,200 |
| 2022/02/07 | 1,036 | 1,046 | 1,024 | 1,037 | +1 | +0.1% | 71,600 |
| 2022/02/04 | 1,020 | 1,038 | 1,015 | 1,036 | +13 | +1.3% | 78,300 |
| 2022/02/03 | 1,030 | 1,035 | 1,015 | 1,023 | -14 | -1.4% | 115,000 |
| 2022/02/02 | 984 | 1,067 | 984 | 1,037 | +63 | +6.5% | 490,300 |
| 2022/02/01 | 981 | 989 | 970 | 974 | -7 | -0.7% | 46,000 |
| 2022/01/31 | 986 | 992 | 973 | 981 | -9 | -0.9% | 49,900 |
| 2022/01/28 | 975 | 1,003 | 970 | 990 | +30 | +3.1% | 93,400 |
| 2022/01/27 | 990 | 993 | 958 | 960 | -24 | -2.4% | 75,300 |
| 2022/01/26 | 975 | 986 | 970 | 984 | +7 | +0.7% | 29,800 |
| 2022/01/25 | 988 | 988 | 973 | 977 | -18 | -1.8% | 29,800 |
| 2022/01/24 | 985 | 998 | 980 | 995 | +8 | +0.8% | 28,900 |
| 2022/01/21 | 967 | 987 | 957 | 987 | +16 | +1.6% | 47,800 |
| 2022/01/20 | 961 | 986 | 961 | 971 | +11 | +1.1% | 56,700 |
| 2022/01/19 | 977 | 985 | 960 | 960 | -28 | -2.8% | 88,900 |
| 2022/01/18 | 1,006 | 1,006 | 988 | 988 | -12 | -1.2% | 42,400 |
| 2022/01/17 | 1,004 | 1,013 | 997 | 1,000 | -10 | -1% | 32,800 |
| 2022/01/14 | 1,026 | 1,026 | 1,000 | 1,010 | -16 | -1.6% | 46,100 |
| 2022/01/13 | 1,042 | 1,047 | 1,025 | 1,026 | -16 | -1.5% | 39,400 |
| 2022/01/12 | 1,011 | 1,043 | 1,010 | 1,042 | +41 | +4.1% | 78,900 |
| 2022/01/11 | 994 | 1,003 | 990 | 1,001 | +13 | +1.3% | 35,700 |
| 2022/01/07 | 990 | 1,001 | 984 | 988 | -7 | -0.7% | 45,700 |
| 2022/01/06 | 1,006 | 1,013 | 995 | 995 | -22 | -2.2% | 49,300 |
| 2022/01/05 | 1,007 | 1,017 | 997 | 1,017 | +9 | +0.9% | 45,200 |
| 2022/01/04 | 1,007 | 1,011 | 999 | 1,008 | +1 | +0.1% | 25,700 |
| 2021/12/30 | 1,016 | 1,016 | 1,005 | 1,007 | -8 | -0.8% | 18,600 |
| 2021/12/29 | 1,000 | 1,015 | 1,000 | 1,015 | +11 | +1.1% | 25,400 |
| 2021/12/28 | 1,015 | 1,018 | 999 | 1,004 | -8 | -0.8% | 37,600 |
| 2021/12/27 | 1,008 | 1,013 | 999 | 1,012 | +4 | +0.4% | 51,200 |
| 2021/12/24 | 1,019 | 1,019 | 997 | 1,008 | -12 | -1.2% | 50,800 |
| 2021/12/23 | 1,018 | 1,033 | 1,012 | 1,020 | +3 | +0.3% | 68,900 |
801～
850
件表示中 / 1029件
類似銘柄と比較する
現在ご覧いただいている「あすかＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| あすかＨＤ | 233,000円 | +16.9% | +33.2% | 2.36% | 12.71倍 | 1.01倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| ネクセラファーマ | 92,000円 | +20.3% | - | 0.00% | 163.12倍 | 1.22倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ＪＣＲファーマ | 55,400円 | +14.3% | - | 3.61% | 22.50倍 | 1.44倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| タウンズ | 56,800円 | +4.6% | +6.1% | 4.93% | 9.68倍 | 3.58倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
| ヘリオス | 54,100円 | +150.0% | - | 0.00% | - | 26.61倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
市場注目の銘柄
チャート関連のコラム
